- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Sarepta Therapeutics Inc
+ Add to WatchlistSRPT:US
36.9100 USD 1.4000 3.94%As of 20:10:00 ET on 05/17/2013.
Snapshot for Sarepta Therapeutics Inc (SRPT)
| Open: | 35.5100 | Day's Range: | 35.1444 - 37.1100 | Volume: | 1,378,336 |
|---|---|---|---|---|---|
| Previous Close: | 35.5100 | 52wk Range: | 3.3000 - 45.0000 | 1-Yr Rtn: | +908.47% |
Key Statistics for SRPT
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -4.6400 |
| Est. EPS (USD) (12/2013) | -3.5220 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1,177.78 |
| Shares Outstanding (M) | 31.91 |
| 30 Day Average Volume | 2,189,627 |
| Price/Book (mrq) | 13.4854 |
| Price/Sale (ttm) | 29.6077 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SRPT
Company Profile & Key Executives for SRPT
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.
| Christopher N GarabedianPresident/CEO | Sandesh Mahatme "Sandy"Senior VP/CFO |
| Edward M KayeSenior VP/Chief Medical Officer | David Tyronne Howton "Ty"Senior VP/Secretary/Gen Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SRPT News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page